| iX Biopharma said it has opened its Entity flagship store on JD Worldwide, JD.com’s cross-border e-commerce platform. JD Worldwide provides a platform for Chinese consumers to purchase authentic imported products and enables international suppliers to sell directly to Chinese consumers without requiring an established presence in China. Chinese consumers will have access to the full range of Entity nutraceuticals on the Entity JD Worldwide store. These include leading products  RestoriX® , a nicotinamide supplement which helps to increase levels of NAD+ (nicotinamide adenine dinucleotide) in the body needed for important cellular functions like energy metabolism, to counter the process of ageing and boost energy levels and vitality; and LumeniX® , a sublingual glutathione wafer. Glutathione is the master antioxidant that helps the body to build stronger immunity to protect against viral infections. LumeniX® offers this, and also promotes skin fairness. |
The launch of the JD Worldwide flagship store is the first foray into the Chinese market by Entity, the nutraceuticals division of iX Biopharma.
This is the first time Entity nutraceuticals will be sold directly to Chinese consumers through an external e-commerce platform, marking an exciting milestone for the Group.
|
Target: Chinese consumers |
|
|
Entity is also preparing a launch of its flagship store on Tmall Global next week.
JD and Tmall are the two largest e-commerce platforms in China, commanding over 85% of the total B2C e-commerce market in China.
Entity nutraceuticals are developed and formulated by Australian scientists and manufactured in the Group’s TGA approved, cGMP-compliant manufacturing facility located in Victoria, Australia.
iX Biopharma said its Entity nutraceuticals are sold in more than 250 pharmacies and health food shops in Sydney, Melbourne and Perth, Australia.
|
Stock price |
15 c |
|
52-week range |
13 – 29 c |
|
Market cap |
S$98 m |
|
PE (ttm) |
- |
|
Dividend yield |
- |
|
1-year return |
-37% |
|
Shares outstanding |
649 m |
|
Source: Bloomberg |
|
Entity nutraceuticals are natural, clinically-supported formulations.
Generic vitamin and mineral supplements that are widely available in the market serve to replenish nutritional deficiencies of a non-ideal diet.
iX Biopharma said Entity nutraceuticals, on the other hand, are designed to produce beneficial and perceptible improvement to a specific condition, and form an important part of a healthcare strategy to prevent more serious diseases.
Entity products are available in Singapore also via its website https://www.entity-health.com/about/